» Articles » PMID: 37243815

Pyroptosis: a New Therapeutic Strategy in Cancer

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2023 May 27
PMID 37243815
Authors
Affiliations
Soon will be listed here.
Abstract

Programmed cell death pathways play important roles in a wide variety of physiological processes. Although it has similarities with apoptosis pyroptosis is a different type of programmed cell death. Pyroptosis can be triggered by different molecules originating from the cells or their environment. Once a pyroptotic pathway is started, it is followed by different molecular steps, and, it ends with the disruption of cell membrane integrity and the onset of inflammatory processes. In addition to the role of pyroptosis in the host's innate immunity against pathogens, uncontrolled pyroptosis can lead to increased inflammation and lead various diseases. The contradictory role of pyroptosis-related molecular changes in the pathogenesis of cancer has attracted attention lately. Excessive or decreased expression of molecules involved in pyroptotic pathways is associated with various cancers. There are ongoing studies on the use of different treatment methods for cancer in combination with new therapies targeting pyroptosis. The potential beneficial effects or side-effect profiles of these protocols targeting pyroptosis still need to be investigated. This will provide us with more efficient and safer options to treat cancer. This review aims to overview the main pathways and mechanisms of pyroptosis and to discuss its role in cancer.

Citing Articles

The regulation of pyroptosis by post-translational modifications: molecular mechanisms and therapeutic targets.

Zhou Y, Dang J, Yang Q, Sun Z EBioMedicine. 2024; 109:105420.

PMID: 39476537 PMC: 11564932. DOI: 10.1016/j.ebiom.2024.105420.


Unlocking the potential of pyroptosis in tumor immunotherapy: a new horizon in cancer treatment.

Yin Q, Song S, Bian Y, Wang Y, Deng A, Lv J Front Immunol. 2024; 15:1381778.

PMID: 38947336 PMC: 11211258. DOI: 10.3389/fimmu.2024.1381778.


Mechanisms of immune checkpoint inhibitors: insights into the regulation of circular RNAS involved in cancer hallmarks.

Meng L, Wu H, Wu J, Ding P, He J, Sang M Cell Death Dis. 2024; 15(1):3.

PMID: 38177102 PMC: 10766988. DOI: 10.1038/s41419-023-06389-5.


Effect of tumor-associated macrophages on the pyroptosis of breast cancer tumor cells.

Ji X, Huang X, Li C, Guan N, Pan T, Dong J Cell Commun Signal. 2023; 21(1):197.

PMID: 37542283 PMC: 10401873. DOI: 10.1186/s12964-023-01208-y.


Bridging Pyroptosis and Immunity: A Comprehensive Study of the Pyroptosis-Related Long Non-Coding RNA Signature in Breast Cancer.

Tian Y, Dong J, Li L Life (Basel). 2023; 13(7).

PMID: 37511974 PMC: 10381440. DOI: 10.3390/life13071599.

References
1.
Vaux D, Korsmeyer S . Cell death in development. Cell. 1999; 96(2):245-54. DOI: 10.1016/s0092-8674(00)80564-4. View

2.
McKenzie B, Dixit V, Power C . Fiery Cell Death: Pyroptosis in the Central Nervous System. Trends Neurosci. 2019; 43(1):55-73. DOI: 10.1016/j.tins.2019.11.005. View

3.
DArcy M . Cell death: a review of the major forms of apoptosis, necrosis and autophagy. Cell Biol Int. 2019; 43(6):582-592. DOI: 10.1002/cbin.11137. View

4.
Hickey E, Raje R, Reid V, Gross S, Ray S . Diclofenac induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic DNA fragmentation and apoptotic cell death. Free Radic Biol Med. 2001; 31(2):139-52. DOI: 10.1016/s0891-5849(01)00560-3. View

5.
Singh R, Letai A, Sarosiek K . Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol. 2019; 20(3):175-193. PMC: 7325303. DOI: 10.1038/s41580-018-0089-8. View